1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Hypertension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bátkai, S; Bukoski, RD; Harvey-White, J; Kunos, G; Liu, J; Mackie, K; Offertáler, L; Osei-Hyiaman, D; Pacher, P; Radaeva, S; Rudd, MA | 1 |
| Abramsky, O; Leker, RR; Ovadia, H; Shohami, E | 1 |
2 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Hypertension
| Article | Year |
|---|---|
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
Topics: Amidohydrolases; Angiotensin II; Animals; Arachidonic Acids; Benzamides; Benzyl Compounds; Blood Pressure; Camphanes; Carbamates; Dronabinol; Endocannabinoids; Endothelium, Vascular; Hypertension; Male; Models, Cardiovascular; Myocardial Contraction; Myocardium; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Up-Regulation; Vascular Resistance; Vasodilation; Ventricular Function, Left | 2004 |
Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemia.
Topics: Animals; Arterial Occlusive Diseases; Disease Models, Animal; Dronabinol; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Hypertension; Ischemic Attack, Transient; Male; Neuroprotective Agents; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Tumor Necrosis Factor-alpha | 1999 |